Advances in systemic lupus erythematosus

Medicine (United Kingdom)

Volumn 46, Issue 2, 2018, Pages 84-92

  Yeoh, Su Ann ^a   Dias, Sofia Sapeta ^a   Isenberg, David A ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Disease activity index; management; MRCP; pathogenesis; systemic lupus erythematosus; treatment

Indexed keywords

ATACICEPT; AUTOANTIGEN; BELIMUMAB; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; OFATUMUMAB; RITUXIMAB;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; APOPTOSIS; B LYMPHOCYTE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXTRACELLULAR TRAP; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMAN; INCIDENCE; INNATE IMMUNITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 85040374413     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2017.11.010     Document Type: Review

References (10)

1. Lewis, M.J., Jawad, A.S., The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatol Oxf 56:suppl 1 (2017), i66–77.
2. Gatto, M., Zen, M., Ghiradello, A., et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12:4 (2013 Feb), 523–536.
3. Gordon, C., Isenberg, D., (eds.) Systemic lupus erythematosus. Oxford Medical Libraries, Oxford Rheumatology Library, 2016, Oxford University Press, Oxford.
4. Petri, M., Orbai, A.M., Alarcón, G.S., et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64 (2012), 2677–2686.
5. Romero-Diaz, J., Isenberg, D., Ramsey-Goldman, R., Measures of adult systemic lupus erythematosus: updated version of British Isles lupus assessment group (BILAG 2004), European consensus lupus activity measurements (ECLAM), systemic lupus activity measure, revised (SLAM-R), systemic lupus activity questionnaire for population studies (SLAQ), systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K), and systemic lupus international collaborating clinics/American College of Rheumatology damage index (SDI). Arthritis Care Res (Hoboken) 63:suppl 11 (2011), S37–S46.
6. Alves, S.C., Fasano, S., Isenberg, D.A., Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Lupus 25:14 (2016), 1509–1519.
7. Bernatsky, S., Boivin, J.F., Joseph, L., et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52:5 (2005), 1481–1490.
8. Medina-Quiñones, C.V., Ramos-Merino, L., Ruiz-Sada, P., et al. Analysis of complete remission in systemic lupus erythematosus patients over a 32-year-period. Arthritis Care Res (Hoboken) 68:7 (2016), 981–987.
9. Zen, M., Iaccarino, L., Gatto, M., et al. Prolonged remission in Caucasian patients with SLE: prevalence and outcomes. Ann Rheum Dis 74:12 (2015), 2117–2122.
10. Wilhelm, T.R., Magder, L.S., Petri, M., Remission in systemic lupus erythematosus: durable remission is rare. Ann Rheum Dis 76:3 (2017), 547–553.